AI and Telemedicine Guidepost has recently launched an AI-powered chatbot to support diabetes management, presenting a potential selling point for healthcare automation, digital patient engagement, and scalable telemedicine solutions that can be offered to partner clinics and insurers.

Tech Enabled Care The company markets a tech-enabled diabetes management programme via partnerships (notably with Discovery Life) that combines telemedicine, clinical analytics, and risk management, suggesting opportunities to expand with health plans, employer wellness programs, and payer-backed chronic disease initiatives.

Growing Scale With a small to mid-size team (11-50 employees) and revenue in the range of one to ten million dollars, Guidepost is positioned to benefit from scalable, low-friction deployment of digital coaching programs to reach more patients without proportional headcount growth.

Diabetes Focus The core offering centers on diabetes mastery through a network of coaches and a telemedicine platform, indicating cross-sell potential to adjacent metabolic health programs, Wellness, and preventive care initiatives within employer and insurer domains.

Geographic Reach Based in Johannesburg with a regional focus on South Africa, there is an opportunity to partner with regional healthcare providers, NGOs, and government programs to expand access, while also exploring regional expansion into nearby markets with similar diabetes burdens.